MARTINI, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 3.173
EU - Europa 895
AS - Asia 887
SA - Sud America 197
AF - Africa 126
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
Totale 5.297
Nazione #
US - Stati Uniti d'America 3.117
CN - Cina 297
SG - Singapore 272
DE - Germania 207
IT - Italia 200
BR - Brasile 145
FI - Finlandia 125
HK - Hong Kong 112
SE - Svezia 63
GB - Regno Unito 56
NL - Olanda 49
VN - Vietnam 44
PL - Polonia 36
RU - Federazione Russa 31
IN - India 29
CI - Costa d'Avorio 19
FR - Francia 18
TR - Turchia 16
AR - Argentina 14
CA - Canada 14
AT - Austria 12
ID - Indonesia 9
AZ - Azerbaigian 8
IL - Israele 8
BD - Bangladesh 7
ES - Italia 7
GR - Grecia 7
SA - Arabia Saudita 7
ZA - Sudafrica 7
CL - Cile 6
EG - Egitto 6
IE - Irlanda 6
JP - Giappone 6
KR - Corea 6
LA - Repubblica Popolare Democratica del Laos 6
MX - Messico 6
SI - Slovenia 6
BW - Botswana 5
CM - Camerun 5
CO - Colombia 5
DZ - Algeria 5
GA - Gabon 5
LB - Libano 5
LT - Lituania 5
MA - Marocco 5
MK - Macedonia 5
NC - Nuova Caledonia 5
NO - Norvegia 5
PE - Perù 5
PY - Paraguay 5
RO - Romania 5
UA - Ucraina 5
VE - Venezuela 5
YT - Mayotte 5
BO - Bolivia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
HR - Croazia 4
IQ - Iraq 4
IR - Iran 4
KG - Kirghizistan 4
LY - Libia 4
MR - Mauritania 4
NG - Nigeria 4
PS - Palestinian Territory 4
AD - Andorra 3
AE - Emirati Arabi Uniti 3
AO - Angola 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BY - Bielorussia 3
CG - Congo 3
CH - Svizzera 3
CY - Cipro 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
ET - Etiopia 3
GN - Guinea 3
GP - Guadalupe 3
GT - Guatemala 3
HN - Honduras 3
HT - Haiti 3
JM - Giamaica 3
KH - Cambogia 3
KW - Kuwait 3
LU - Lussemburgo 3
MD - Moldavia 3
MN - Mongolia 3
PH - Filippine 3
TT - Trinidad e Tobago 3
UG - Uganda 3
UY - Uruguay 3
VC - Saint Vincent e Grenadine 3
XK - ???statistics.table.value.countryCode.XK??? 3
YE - Yemen 3
ZM - Zambia 3
ZW - Zimbabwe 3
AM - Armenia 2
BF - Burkina Faso 2
Totale 5.216
Città #
Fairfield 450
Ashburn 341
Chandler 291
Woodbridge 290
Houston 235
Ann Arbor 222
Singapore 169
Cambridge 167
Seattle 167
Wilmington 143
Munich 127
Hong Kong 110
Helsinki 82
Beijing 76
Boardman 64
Santa Clara 49
Padova 46
New York 40
San Diego 39
Princeton 33
Des Moines 32
Medford 31
Bytom 29
Nanjing 27
Guangzhou 21
Dong Ket 20
Abidjan 19
São Paulo 15
Jinan 14
Chicago 13
Shenyang 12
Turku 12
Ankara 11
Changsha 11
Falls Church 11
Los Angeles 11
Redwood City 11
Rome 11
London 10
Shanghai 10
Dallas 9
Milan 9
San Francisco 9
Amsterdam 8
Baku 8
Brooklyn 8
Hefei 8
Nanchang 7
Nuremberg 7
Cagliari 6
Hangzhou 6
Hanoi 6
Jiaxing 6
Phoenix 6
Redmond 6
Athens 5
Chennai 5
Dublin 5
Falkenstein 5
Frankfurt am Main 5
Hebei 5
Johannesburg 5
Jyväskylä 5
Libreville 5
Lima 5
Noumea 5
Pune 5
Rio de Janeiro 5
Seoul 5
Skopje 5
Taiyuan 5
Taizhou 5
Tel Aviv 5
Tokyo 5
Vienna 5
Vientiane 5
Warsaw 5
Bologna 4
Council Bluffs 4
Douala 4
Haikou 4
Ho Chi Minh City 4
Lagos 4
Ljubljana 4
Montreal 4
Recife 4
Riyadh 4
Roxbury 4
Salvador 4
Santiago 4
Stockholm 4
Zhengzhou 4
Asunción 3
Belo Horizonte 3
Bishkek 3
Conakry 3
Denver 3
Detroit 3
Ferrara 3
Fuzhou 3
Totale 3.775
Nome #
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole. 287
Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients 254
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F+IL-23+ CD161+ CD4+ T helper cells in psoriatic arthritis joints 241
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo 240
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia 225
Cortactin, another player in the Lyn signaling pathway, is overexpressed and alternatively spliced in leukemic cells from patients with B-cell Chronic Lymphocytic Leukemia. 202
Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia 197
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins 194
Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints 192
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. 185
Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments 180
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 176
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia 175
Interaction between the SH3 domain of Src family kinases and the proline-rich motif of HTLV-1 p13: a novel mechanism underlying delivery of Src family kinases to mitochondria. 174
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival 174
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia 171
ESPRESSIONE DELLA CORTACTINA E SUO COINVOLGIMENTO NELL'AGGRESSIVITA' DELLA LEUCEMIA LINFATICA CRONICA B 166
Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic Leukemia 159
p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes 152
From macro to nano: Linking quantitative CEUS perfusion parameters to CD4+ T cells subtypes in spondyloarthtitis 142
Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia. 139
HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen. 134
CLL patients carrying 13q deletion show clinical heterogenity according to IGVH mutational status and CD38 expression 131
Intrinsic and Estrinsic Mechanism Contributes to Maintain the JAK/STAT Pathway Aberrantly Activated in T-Type Large Granular Lymphocyte Leukemia 127
Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma 127
Increased Survival and Migration of CLL B-Cells in the Presence of Marrow Mesenchymal Stromal Cells: Novel Findings for Microenvironment-Targeted Therapies 122
Targeting Brutons Tyrosine Kinase in Chronic Lymphocytic Leukemia at the Crossroad between Intrinsic and Extrinsic Pro-survival Signals 121
Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model 121
Phosphorylation of PP2A by Lyn is a key phenomenon in the cancer phenotype of B-CLL 117
B cells from Chronic Lymphocytic Leukemia undergo apoptosis following microtubule depolymerization by nocodazole 103
CLL patients with low-risk cytogenetic abnormalities show clinical heterogeneity according to IGVH mutational status and CD38 expression 99
Leukemic cell from B-CLL patients display heterogeneous response to the anti-apoptotic effect of mesenchymal stromal cells 94
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 59
Totale 5.380
Categoria #
all - tutte 18.241
article - articoli 17.047
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.288


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021529 0 0 27 38 29 29 26 55 71 144 63 47
2021/2022542 11 49 54 64 42 32 31 51 49 9 29 121
2022/2023532 85 60 21 91 64 49 4 40 65 10 33 10
2023/2024321 32 31 28 21 31 65 10 26 8 26 15 28
2024/20251.161 7 62 57 52 110 73 79 132 112 35 167 275
2025/2026762 215 339 208 0 0 0 0 0 0 0 0 0
Totale 5.380